CHARLOTTES WEB HOLDINGS INC (CWEB.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:CWEB - CA16106R1091 - Common Stock
0.285 CAD
+0 (+1.79%)
Overall CWEB gets a fundamental rating of 2 out of 10. We evaluated CWEB against 32 industry peers in the Pharmaceuticals industry. CWEB may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, CWEB is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year CWEB has reported negative net income.
In the past year CWEB has reported a negative cash flow from operations.
CWEB had negative earnings in each of the past 5 years.
CWEB had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -26.58%, CWEB is doing worse than 73.33% of the companies in the same industry.
Looking at the Return On Equity, with a value of -234.52%, CWEB is doing worse than 83.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -26.58% | ||
| ROE | -234.52% | ||
| ROIC | N/A |
ROA(3y)-24.53%
ROA(5y)-32.75%
ROE(3y)-76.52%
ROE(5y)-69.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CWEB's Gross Margin of 44.26% is in line compared to the rest of the industry. CWEB outperforms 60.00% of its industry peers.
CWEB's Gross Margin has declined in the last couple of years.
CWEB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.26% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.4%
GM growth 5Y-4.67%
2. Health
2.1 Basic Checks
CWEB does not have a ROIC to compare to the WACC, probably because it is not profitable.
CWEB has more shares outstanding than it did 1 year ago.
CWEB has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CWEB is higher compared to a year ago.
2.2 Solvency
CWEB has an Altman-Z score of -5.05. This is a bad value and indicates that CWEB is not financially healthy and even has some risk of bankruptcy.
CWEB has a Altman-Z score of -5.05. This is amonst the worse of the industry: CWEB underperforms 80.00% of its industry peers.
CWEB has a Debt/Equity ratio of 5.28. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CWEB (5.28) is worse than 86.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.28 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.05 |
ROIC/WACCN/A
WACC8.39%
2.3 Liquidity
A Current Ratio of 3.89 indicates that CWEB has no problem at all paying its short term obligations.
The Current ratio of CWEB (3.89) is better than 86.67% of its industry peers.
A Quick Ratio of 1.65 indicates that CWEB should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.65, CWEB is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.89 | ||
| Quick Ratio | 1.65 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 39.15% over the past year.
CWEB shows a decrease in Revenue. In the last year, the revenue decreased by -6.83%.
The Revenue for CWEB have been decreasing by -12.09% on average. This is quite bad
EPS 1Y (TTM)39.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.27%
Revenue 1Y (TTM)-6.83%
Revenue growth 3Y-19.75%
Revenue growth 5Y-12.09%
Sales Q2Q%-8.61%
3.2 Future
Based on estimates for the next years, CWEB will show a very strong growth in Earnings Per Share. The EPS will grow by 22.76% on average per year.
Based on estimates for the next years, CWEB will show a quite strong growth in Revenue. The Revenue will grow by 8.01% on average per year.
EPS Next Y35%
EPS Next 2Y28.45%
EPS Next 3Y22.76%
EPS Next 5YN/A
Revenue Next Year5.55%
Revenue Next 2Y7.32%
Revenue Next 3Y8.01%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CWEB. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CWEB. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
CWEB's earnings are expected to grow with 22.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.45%
EPS Next 3Y22.76%
5. Dividend
5.1 Amount
CWEB does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX:CWEB (12/19/2025, 7:00:00 PM)
0.285
+0 (+1.79%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners1.4%
Inst Owner ChangeN/A
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap45.43M
Revenue(TTM)49.24M
Net Income(TTM)-21.69M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-12.85%
Min Revenue beat(2)-17.08%
Max Revenue beat(2)-8.61%
Revenue beat(4)0
Avg Revenue beat(4)-14.49%
Min Revenue beat(4)-26.52%
Max Revenue beat(4)-5.76%
Revenue beat(8)0
Avg Revenue beat(8)-15.8%
Revenue beat(12)0
Avg Revenue beat(12)-15.91%
Revenue beat(16)0
Avg Revenue beat(16)-16.91%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-62.5%
EPS NY rev (3m)-62.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.51%
Revenue NY rev (1m)-2.18%
Revenue NY rev (3m)-2.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.67 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.56 | ||
| P/tB | 3.95 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.19
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0.43
BVpS0.08
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -26.58% | ||
| ROE | -234.52% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.26% | ||
| FCFM | N/A |
ROA(3y)-24.53%
ROA(5y)-32.75%
ROE(3y)-76.52%
ROE(5y)-69.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.4%
GM growth 5Y-4.67%
F-Score4
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.28 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 12.21% | ||
| Cap/Sales | 1.77% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.89 | ||
| Quick Ratio | 1.65 | ||
| Altman-Z | -5.05 |
F-Score4
WACC8.39%
ROIC/WACCN/A
Cap/Depr(3y)21.98%
Cap/Depr(5y)104.62%
Cap/Sales(3y)4.65%
Cap/Sales(5y)9.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.27%
EPS Next Y35%
EPS Next 2Y28.45%
EPS Next 3Y22.76%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.83%
Revenue growth 3Y-19.75%
Revenue growth 5Y-12.09%
Sales Q2Q%-8.61%
Revenue Next Year5.55%
Revenue Next 2Y7.32%
Revenue Next 3Y8.01%
Revenue Next 5YN/A
EBIT growth 1Y44.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.55%
EBIT Next 3Y29.12%
EBIT Next 5YN/A
FCF growth 1Y19.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.84%
OCF growth 3YN/A
OCF growth 5YN/A
CHARLOTTES WEB HOLDINGS INC / CWEB.CA FAQ
What is the fundamental rating for CWEB stock?
ChartMill assigns a fundamental rating of 2 / 10 to CWEB.CA.
What is the valuation status of CHARLOTTES WEB HOLDINGS INC (CWEB.CA) stock?
ChartMill assigns a valuation rating of 1 / 10 to CHARLOTTES WEB HOLDINGS INC (CWEB.CA). This can be considered as Overvalued.
Can you provide the profitability details for CHARLOTTES WEB HOLDINGS INC?
CHARLOTTES WEB HOLDINGS INC (CWEB.CA) has a profitability rating of 0 / 10.
Can you provide the expected EPS growth for CWEB stock?
The Earnings per Share (EPS) of CHARLOTTES WEB HOLDINGS INC (CWEB.CA) is expected to grow by 35% in the next year.